Xiaojuan Lian

678 citations
15 papers · 365 indexed · 1 hit paper · h-index 9
Topics
SARS-CoV-2 and COVID-19 Research (4 papers)Autophagy in Disease and Therapy (3 papers)Vaccine Coverage and Hesitancy (3 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
Partner nations
ChinaAustraliaTaiwan

In The Last Decade

Xiaojuan Lian

14 papers receiving 359 citations

Hit Papers

Safety, tolerability, and immunogenicity of an inactivate...2021202620222024202150100150200

Peers

Xiaojuan Lian
Comparison fields: 5 of 76
  • Infectious Diseases 219
  • Health 123
  • Molecular Biology 81
  • Obstetrics and Gynecology 46
  • Pulmonary and Respiratory Medicine 42
Replace Xiaofang Fu with:
Xiaofang Fu China
Faisal Minshawi Saudi Arabia
Priyanka Firmal India
Nassiba Taib Qatar
Lobna Al-Zaidan Qatar
Carmen Olmedo Spain
Sushil Sharma India
Khaled Albakri Jordan
Anne J. Grotenhuis Netherlands
Berhanu Woldu Ethiopia
Xiaojuan Lian relative to Xiaofang Fu China Xiaofang Fu's profile →
Citations per field
00.5×6.6×
Xiaofang Fu · 1×
Citations per year

Countries citing papers authored by Xiaojuan Lian

Since Specialization
Citations

This map shows the geographic impact of Xiaojuan Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Lian more than expected).

Fields of papers citing papers by Xiaojuan Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojuan Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Lian. The network helps show where Xiaojuan Lian may publish in the future.

Co-authorship network of co-authors of Xiaojuan Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojuan Lian. A scholar is included among the top collaborators of Xiaojuan Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojuan Lian. Xiaojuan Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 12
3 2
4 8
5 4
6 6
7
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trialbreakdown →
211
8 15
9
ZEB1 promotes colorectal cancer cell invasion and disease progression by enhanced LOXL2 transcription.
12
10 12
11
Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway.
18
12 8
13 4
14 35
15 18

About Xiaojuan Lian

Xiaojuan Lian is a scholar working on Applied Microbiology and Biotechnology, Health and Geriatrics and Gerontology, having authored 15 papers that have together received 365 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Autophagy in Disease and Therapy (3 papers) and Vaccine Coverage and Hesitancy (3 papers). The work is most often cited by research in Health (123 citations), Infectious Diseases (219 citations) and Obstetrics and Gynecology (46 citations). Xiaojuan Lian has collaborated with scholars based in China, Australia and Taiwan. Frequent co-authors include Changgui Li, Zhiwei Jiang, Bihua Han, Zhiwei Wu, Yufei Song, Lei Wang, Qun Shu, Minjie Li, Wanqi Yang and Wenbin Jiao. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026